Evidence map›Paper›PMID 37339833›Full record

ArticleBMJ open2023

Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study.

Rui Huang, Jian-Gao Fan, Jun-Ping Shi, Yi-Min Mao, Bing-Yuan Wang, Jing-Min Zhao, Lun Gen Lu, Bi-Hui Zhong, Zheng-Sheng Zou, You-Qing Xu and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 1 country.

Rui HuangPeking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China.
Jian-Gao FanDepartment of Hepatology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Jun-Ping ShiDepartment of Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Yi-Min MaoDepartment of Digestive, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Bing-Yuan WangDepartment of Digestive, The First Hospital of China Medical University, Shenyang, China.
Jing-Min ZhaoDepartment of Pathology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Lun Gen LuDepartment of Hepatology, The First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Bi-Hui ZhongDepartment of Digestive, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Zheng-Sheng ZouDepartment of Pathology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
You-Qing XuDepartment of Digestive, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yi-Nong YeDepartment of Infectious Disease, The First Hospital of Fushan, Fushan, China.
Longgen LiuDepartment of Hepatology, Third People's Hospital of Changzhou, Changzhou, China.
Lian-Jie LinDepartment of Digestive, Shengjing Hospital of China Medical University, Shenyang, China.
Huiying RaoPeking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China raohuiying@pkuph.edu.cn weilai@mail.tsinghua.edu.cn.ORCID 0000-0003-2431-3872
Lai WeiHepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China raohuiying@pkuph.edu.cn weilai@mail.tsinghua.edu.cn.
Chinese PLA General Hospital · CNPeking University · CNShanghai Jiao Tong University · CNAffiliated Hospital of Hangzhou Normal University · CNBeijing Tsinghua Chang Gung Hospital · CNCapital Medical University · CNChangzhou Third People's Hospital · CNChina Medical University · CNFirst Hospital of China Medical University · CNSun Yat-sen University · CNXinHua Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNon-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of chronic liver disease worldwide. However, treatment of NAFLD is potentially influenced by psychological conditions. Using the simplified version of the University of Rhode Island Change Assessment (URICA-SV) scale, this study aimed to evaluate the stage of psychological change as a prerequisite to refining implementation strategies for psychological change.

designA multicentre cross-sectional survey.

settingNinety hospitals in China.

participants5181 patients with NAFLD were included in this study. OUTCOME MEASURES: All patients completed the URICA-SV questionnaire and were assigned to one of the three stages of change (precontemplation, contemplation or action) according to their readiness scores. A stepwise multivariate logistic regression analysis was used to identify independent factors associated with the stage of psychological change.

resultsA total of 4832 (93.3%) patients were included in the precontemplation stage and only 349 (6.7%) considered making a change or preparing to make one. There were significant differences in gender (Cohen's d=0.039, p=0.005), age (Cohen's d=-0.327, p<0.001), waist circumference (Cohen's d=0.143, p=0.003), alanine transaminase (Cohen's d=0.347, p=0.001), triglyceride (Cohen's d=0.351, p=0.002), body mass index (BMI; Cohen's d=0.056, p<0.001), proportion of hyperlipidaemia (Cohen's d=0.068, p<0.001) and cardiovascular disease (Cohen's d=0.032, p=0.029), therapeutic regimen (Cohen's d=0.136, p<0.001), and Chronic Liver Disease Questionnaire-Non-Alcoholic Fatty Liver Disease overall score (Cohen's d=-0.420, p<0.001) between patients with NAFLD in the precontemplation stage and those in the contemplation/action stage. Logistic regression identified BMI (HR 0.659, 95% CI 0.469 to 0.928, p=0.017), cardiovascular disease (HR 2.161, 95% CI 1.089 to 4.287, p=0.027) and triglyceride (HR 0.751, 95% CI 0.591 to 0.955, p=0.020) as independent factors predicting psychological change.

conclusionsThe results demonstrated that very few patients with NAFLD presented psychological condition in the stage of action. Psychological condition was found to be significantly related to BMI, cardiovascular disease and triglyceride factors. Integrated diversity considerations for evaluating psychological change are necessary.

Indexed as

Cardiovascular DiseasesMetabolic DiseasesNon-alcoholic Fatty Liver DiseaseChinaCross-Sectional StudiesHumansTriglyceridesTriglycerideshealth & safetyhepatobiliary diseasehepatology

Identifiers

PMID37339833
PMCPMC10314458
OpenAlexW4381436072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.